Dec 22, 2025 8:00 am EST Vyome Subsidiary LiveChain (LICH) to Acquire Senior Secured Note in Humanyze, An MIT Incubated Company
Dec 8, 2025 8:00 am EST Vyome Reports Positive Final Phase 2 Results for VT-1953; Plans to Advance Into Pivotal Study For FDA Approval
Nov 25, 2025 7:00 am EST Vyome Appoints Renowned Medical Oncologist, Dr. Aditya Bardia, as Senior Medical Advisor to Guide the Development of MFW Program
Nov 18, 2025 7:00 am EST Vyome Holdings Announces Transformational First Quarter Following Nasdaq Listing
Sep 17, 2025 7:00 am EDT Vyome Presents Strong Data Showing Topical VT-1908 is an Effective Treatment for Uveitis, Opening Up a $3B Addressable Market Opportunity
Sep 9, 2025 8:30 am EDT Vyome Holdings Strengthens Leadership Team with Industry Veterans as it plans Pivotal Trial Studies
Sep 4, 2025 8:30 am EDT Vyome Holdings Announces Positive Interim Data from Phase 2 Study of VT-1953 in Malignant Fungating Wounds (MFW) and Provides Update on MFW market opportunity
Aug 21, 2025 7:00 am EDT Vyome Signs MoU with Embryyo, India’s Leading Medical Device Innovation Studio
